Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma

SIMPLE SUMMARY: Renal cell carcinoma (RCC) is a heterogeneous and complex disease with almost no response to chemotherapy. Immune checkpoint inhibitors have achieved great clinical success but no interesting circulating markers of clinical use have developed so far in clear cell renal cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Larrinaga, Gorka, Solano-Iturri, Jon Danel, Errarte, Peio, Unda, Miguel, Loizaga-Iriarte, Ana, Pérez-Fernández, Amparo, Echevarría, Enrique, Asumendi, Aintzane, Manini, Claudia, Angulo, Javier C., López, José I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915750/
https://www.ncbi.nlm.nih.gov/pubmed/33562338
http://dx.doi.org/10.3390/cancers13040667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915750/
https://www.ncbi.nlm.nih.gov/pubmed/33562338
http://dx.doi.org/10.3390/cancers13040667

Ejemplares similares